The move to reduce prescription copays for Medicare beneficiaries comes as a result of the Inflation Reduction Act and will apply for the final three months of the year beginning Oct. 1, CMS said. The concept is to mitigate against drug company price increases that are above the rate of inflation.
The drug savings are for medications under Medicare Part B plans.
A list of the affected drugs can be found here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
